CIP
ZYME icon

Chartwell Investment Partners’s Zymeworks ZYME Stock Holding History

Chartwell Investment Partners’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,211
Closed -$260K – 434
2020
Q2 		$260K Sell
7,211
-2,121
-23% -$78.1K 0.01% 401
2020
Q1 		$331K Buy
9,332
+1,174
+14% +$48K 0.02% 379
2019
Q4 		$371K Buy
+8,158
New +$296K 0.01% 392

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Chartwell Investment Partners's ZYME Position: Q3 2020 in Review

Chartwell Investment Partners sold out of Zymeworks (ZYME) in Q3 2020, closing a stake of 7,211 shares — an estimated $260K sold.

Chartwell Investment Partners first reported a position in ZYME in Q4 2019 and held it in 3 quarters. The position peaked at $371K in Q4 2019. 127 funds tracked by Wall St. Rank hold ZYME as of Q3 2020.

  • Chartwell Investment Partners reported no remaining Zymeworks position as of Q3 2020 after selling out during the quarter.
  • Chartwell Investment Partners sold 7,211 Zymeworks shares in Q3 2020, an estimated $260K.
  • Chartwell Investment Partners first reported a position in Zymeworks in Q4 2019 and held it in 3 quarters.
  • Chartwell Investment Partners's Zymeworks position peaked at $371K in Q4 2019.
  • 127 funds tracked by Wall St. Rank held Zymeworks as of Q3 2020.

Based on Chartwell Investment Partners's 13F filing for Q3 2020, filed 16 Nov 2020.